페이스메이커 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 기술별, 제품 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Pacemaker Market, valued at USD 5.10 Billion in 2024, is projected to experience a CAGR of 4.47% to reach USD 6.63 Billion by 2030. A pacemaker is an implanted medical device designed to generate electrical impulses, thereby regulating abnormal heart rhythms. The global pacemaker market's growth is primarily driven by the increasing worldwide prevalence of cardiovascular diseases and the expanding geriatric population, as advanced age is a key risk factor for cardiac arrhythmias. Further impetus comes from continuous technological advancements, including device miniaturization, enhanced battery longevity, and integrated remote monitoring capabilities.

Key Market Drivers

The rising prevalence of cardiovascular diseases serves as a fundamental driver for the global pacemaker market. Cardiac conditions, particularly those involving rhythm disorders such as bradycardia, frequently necessitate pacemaker implantation to restore and maintain proper heart function. This increasing disease burden is observable globally, creating a continuous demand for advanced cardiac rhythm management solutions. According to a new study published in JACC, January 2024, 'New Study Reveals Latest Data on Global Burden of Cardiovascular Disease', global death counts attributed to cardiovascular disease rose to 19.8 million in 2022. The persistent rise in these complex conditions underscores the critical need for effective interventions, directly expanding the patient pool eligible for pacemaker therapy.

Key Market Challenges

The elevated cost of advanced pacemaker devices and associated implantation procedures presents a significant impediment to the global pacemaker market's expansion. This financial barrier directly restricts patient accessibility and affordability, particularly in regions with developing healthcare infrastructures and lower per capita income. The high upfront investment required for these medical devices, coupled with the expenses of specialized surgical procedures and ongoing follow-up care, creates a substantial economic burden for healthcare systems and individual patients alike.

Key Market Trends

The global pacemaker market is significantly influenced by the growing adoption of leadless pacemakers. These miniaturized devices, implanted directly into the heart without leads or a surgical pocket, reduce the risk of complications associated with traditional transvenous systems. For instance, a March 2024 summary by the American College of Cardiology highlighted a post-approval registry finding that Micra leadless pacemakers had a major complication rate of 4.1% at 36 months, which was significantly lower than the 8.5% observed for transvenous systems. This reduction in complications contributes to improved patient outcomes and expanded indications for leadless therapy.

Key Market Players

• Medtronic PLC
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Sorin Group
• Abbott Laboratories Inc.
• Edwards Lifesciences Corporation
• B. Braun Melsungen AG
• Osypka Medical GmbH
• Medico S.p.A
• Oscor, Inc.

Report Scope:

In this report, the Global Pacemaker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pacemaker Market, By Type:

• Implantable
• External

Pacemaker Market, By Technology:

• Dual Chamber
• Single Chamber
• Biventricular Chamber

Pacemaker Market, By Product Type:

• MRI Compatible
• Conventional

Pacemaker Market, By Applications:

• Arrythmias
• Congestive Heart Failure
• Others

Pacemaker Market, By End User:

• Hospitals
• Cardiac Care Centers
• Ambulatory Surgical Centers

Pacemaker Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pacemaker Market.

Available Customizations:

Global Pacemaker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pacemaker Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Implantable, External)
  • 5.2.2. By Technology (Dual Chamber, Single Chamber, Biventricular Chamber)
  • 5.2.3. By Product Type (MRI Compatible, Conventional)
  • 5.2.4. By Applications (Arrythmias, Congestive Heart Failure, Others)
  • 5.2.5. By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Pacemaker Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Product Type
  • 6.2.4. By Applications
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pacemaker Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Product Type
      • 6.3.1.2.4. By Applications
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Pacemaker Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Product Type
      • 6.3.2.2.4. By Applications
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Pacemaker Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Product Type
      • 6.3.3.2.4. By Applications
      • 6.3.3.2.5. By End User

7. Europe Pacemaker Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Product Type
  • 7.2.4. By Applications
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pacemaker Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Product Type
      • 7.3.1.2.4. By Applications
      • 7.3.1.2.5. By End User
  • 7.3.2. France Pacemaker Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Product Type
      • 7.3.2.2.4. By Applications
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Pacemaker Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Product Type
      • 7.3.3.2.4. By Applications
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Pacemaker Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Product Type
      • 7.3.4.2.4. By Applications
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Pacemaker Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Product Type
      • 7.3.5.2.4. By Applications
      • 7.3.5.2.5. By End User

8. Asia Pacific Pacemaker Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Product Type
  • 8.2.4. By Applications
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pacemaker Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Product Type
      • 8.3.1.2.4. By Applications
      • 8.3.1.2.5. By End User
  • 8.3.2. India Pacemaker Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Product Type
      • 8.3.2.2.4. By Applications
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Pacemaker Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Product Type
      • 8.3.3.2.4. By Applications
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Pacemaker Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Product Type
      • 8.3.4.2.4. By Applications
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Pacemaker Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Product Type
      • 8.3.5.2.4. By Applications
      • 8.3.5.2.5. By End User

9. Middle East & Africa Pacemaker Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Product Type
  • 9.2.4. By Applications
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pacemaker Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Product Type
      • 9.3.1.2.4. By Applications
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Pacemaker Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Product Type
      • 9.3.2.2.4. By Applications
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Pacemaker Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Product Type
      • 9.3.3.2.4. By Applications
      • 9.3.3.2.5. By End User

10. South America Pacemaker Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Product Type
  • 10.2.4. By Applications
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pacemaker Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Product Type
      • 10.3.1.2.4. By Applications
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Pacemaker Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Product Type
      • 10.3.2.2.4. By Applications
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Pacemaker Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Product Type
      • 10.3.3.2.4. By Applications
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pacemaker Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston Scientific Corporation
• 15.3. BIOTRONIK SE & Co. KG
• 15.4. Sorin Group
• 15.5. Abbott Laboratories Inc.
• 15.6. Edwards Lifesciences Corporation
• 15.7. B. Braun Melsungen AG
• 15.8. Osypka Medical GmbH
• 15.9. Medico S.p.A
• 15.10. Oscor, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer